The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Using a generative co-design framework to adapt an exercise intervention as part of a multimodal intervention for patients’ receiving haemodialysis with or at risk of renal cachexia

Blair C, Slee A, McKeaveney C, Maxwell AP, Awan F, Brown M, Carson M, Comer S, Davenport A, Fogarty D, Fouque D, Gooding O, McKinley[...]

How Far Is a Kidney Willing to Go? Kidney Transplant Outcomes Based on Distance Donor Kidney Travels to Transplant Centers

Datta N, Qureshi A, Ebadyrad M, Thi Pham PT, Hamiduzzaman A, Pirzadeh A, Velazquez A, Bunnapradist S, Lum EL. How Far Is a Kidney Willing[...]

Kassem Safa, MD Appointed Medical Director of the UCLA Kidney Transplant Program

The UCLA Department of Medicine has appointed Kassem Safa, MD, as medical director of the UCLA Kidney Transplant Program in the division of nephrology, effective[...]